Annual CFO:
-$52.02M+$43.12M(+45.32%)Summary
- As of today, BCRX annual cash from operations is -$52.02 million, with the most recent change of +$43.12 million (+45.32%) on December 31, 2024.
- During the last 3 years, BCRX annual cash from operations has risen by +$90.14 million (+63.41%).
- BCRX annual cash from operations is now -1537.08% below its all-time high of -$3.18 million, reached on December 31, 2000.
Performance
BCRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$41.30M+$68.82M(+250.10%)Summary
- As of today, BCRX quarterly cash from operations is $41.30 million, with the most recent change of +$68.82 million (+250.10%) on June 30, 2025.
- Over the past year, BCRX quarterly cash from operations has increased by +$42.67 million (+3119.15%).
- BCRX quarterly cash from operations is now at all-time high.
Performance
BCRX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$16.82M+$42.67M(+165.05%)Summary
- As of today, BCRX TTM cash from operations is $16.82 million, with the most recent change of +$42.67 million (+165.05%) on June 30, 2025.
- Over the past year, BCRX TTM cash from operations has increased by +$100.68 million (+120.05%).
- BCRX TTM cash from operations is now at all-time high.
Performance
BCRX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BCRX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +45.3% | +3119.2% | +120.0% |
| 3Y3 Years | +63.4% | +248.8% | +110.4% |
| 5Y5 Years | +41.9% | +233.1% | +116.3% |
BCRX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +67.9% | at high | +176.9% | at high | +109.9% |
| 5Y | 5-Year | at high | +67.9% | at high | +153.1% | at high | +109.7% |
| All-Time | All-Time | -1537.1% | +67.9% | at high | +153.1% | at high | +109.7% |
BCRX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $41.30M(+250.1%) | $16.82M(+165.0%) |
| Mar 2025 | - | -$27.52M(-427.9%) | -$25.85M(+50.3%) |
| Dec 2024 | -$52.02M(+45.3%) | -$5.21M(-163.2%) | -$52.02M(+6.6%) |
| Sep 2024 | - | $8.24M(+702.7%) | -$55.73M(+33.6%) |
| Jun 2024 | - | -$1.37M(+97.5%) | -$83.87M(+17.2%) |
| Mar 2024 | - | -$53.68M(-502.0%) | -$101.31M(-6.5%) |
| Dec 2023 | -$95.14M(+41.2%) | -$8.92M(+55.2%) | -$95.14M(+13.6%) |
| Sep 2023 | - | -$19.90M(-5.8%) | -$110.07M(+10.2%) |
| Jun 2023 | - | -$18.81M(+60.4%) | -$122.62M(+6.8%) |
| Mar 2023 | - | -$47.51M(-99.2%) | -$131.56M(+18.7%) |
| Dec 2022 | -$161.85M(-13.9%) | -$23.85M(+26.5%) | -$161.85M(+5.1%) |
| Sep 2022 | - | -$32.44M(-16.9%) | -$170.46M(-5.7%) |
| Jun 2022 | - | -$27.76M(+64.3%) | -$161.29M(-1.5%) |
| Mar 2022 | - | -$77.80M(-139.7%) | -$158.95M(-11.8%) |
| Dec 2021 | -$142.16M(-5.2%) | -$32.46M(-39.5%) | -$142.16M(+6.6%) |
| Sep 2021 | - | -$23.28M(+8.4%) | -$152.23M(+9.0%) |
| Jun 2021 | - | -$25.41M(+58.4%) | -$167.21M(+3.3%) |
| Mar 2021 | - | -$61.01M(-43.5%) | -$172.84M(-27.9%) |
| Dec 2020 | -$135.11M(-50.8%) | -$42.53M(-11.2%) | -$135.11M(-31.1%) |
| Sep 2020 | - | -$38.26M(-23.2%) | -$103.03M(-11.5%) |
| Jun 2020 | - | -$31.04M(-33.3%) | -$92.41M(-7.6%) |
| Mar 2020 | - | -$23.28M(-122.8%) | -$85.87M(+4.1%) |
| Dec 2019 | -$89.58M(+3.2%) | -$10.45M(+62.2%) | -$89.58M(+13.1%) |
| Sep 2019 | - | -$27.64M(-12.8%) | -$103.12M(+6.7%) |
| Jun 2019 | - | -$24.50M(+9.2%) | -$110.52M(-10.6%) |
| Mar 2019 | - | -$27.00M(-12.6%) | -$99.91M(-7.9%) |
| Dec 2018 | -$92.56M(-125.0%) | -$23.98M(+31.5%) | -$92.56M(-17.0%) |
| Sep 2018 | - | -$35.03M(-152.1%) | -$79.10M(-40.0%) |
| Jun 2018 | - | -$13.89M(+29.3%) | -$56.50M(-8.1%) |
| Mar 2018 | - | -$19.65M(-86.8%) | -$52.27M(-27.0%) |
| Dec 2017 | -$41.14M(+23.0%) | -$10.52M(+15.4%) | -$41.14M(-12.8%) |
| Sep 2017 | - | -$12.43M(-28.6%) | -$36.48M(+12.3%) |
| Jun 2017 | - | -$9.67M(-13.4%) | -$41.61M(+3.5%) |
| Mar 2017 | - | -$8.53M(-45.7%) | -$43.12M(+19.3%) |
| Dec 2016 | -$53.44M(-307.4%) | -$5.85M(+66.7%) | -$53.44M(+14.4%) |
| Sep 2016 | - | -$17.56M(-57.0%) | -$62.41M(-8.5%) |
| Jun 2016 | - | -$11.18M(+40.6%) | -$57.51M(-103.7%) |
| Mar 2016 | - | -$18.84M(-27.1%) | -$28.23M(-115.2%) |
| Dec 2015 | -$13.12M(+66.0%) | -$14.83M(-17.1%) | -$13.12M(-7.7%) |
| Sep 2015 | - | -$12.66M(-170.0%) | -$12.18M(-50.0%) |
| Jun 2015 | - | $18.10M(+585.7%) | -$8.12M(+75.6%) |
| Mar 2015 | - | -$3.73M(+73.2%) | -$33.32M(+13.6%) |
| Dec 2014 | -$38.55M(-45.3%) | -$13.89M(-61.5%) | -$38.55M(-32.1%) |
| Sep 2014 | - | -$8.60M(-21.1%) | -$29.18M(-2.4%) |
| Jun 2014 | - | -$7.10M(+20.7%) | -$28.50M(-17.3%) |
| Mar 2014 | - | -$8.96M(-98.4%) | -$24.29M(+8.4%) |
| Dec 2013 | -$26.53M(+29.1%) | -$4.51M(+43.0%) | -$26.53M(+8.7%) |
| Sep 2013 | - | -$7.92M(-173.6%) | -$29.05M(+11.7%) |
| Jun 2013 | - | -$2.90M(+74.1%) | -$32.90M(+9.5%) |
| Mar 2013 | - | -$11.20M(-59.3%) | -$36.35M(+2.8%) |
| Dec 2012 | -$37.40M(-16.0%) | -$7.03M(+40.3%) | -$37.40M(-8.9%) |
| Sep 2012 | - | -$11.78M(-85.7%) | -$34.35M(-4.0%) |
| Jun 2012 | - | -$6.34M(+48.2%) | -$33.04M(-9.5%) |
| Mar 2012 | - | -$12.25M(-207.4%) | -$30.17M(+6.4%) |
| Dec 2011 | -$32.25M(-12.9%) | -$3.98M(+61.9%) | -$32.25M(+5.4%) |
| Sep 2011 | - | -$10.47M(-201.6%) | -$34.09M(-3.8%) |
| Jun 2011 | - | -$3.47M(+75.8%) | -$32.85M(+12.9%) |
| Mar 2011 | - | -$14.33M(-146.2%) | -$37.69M(-32.0%) |
| Dec 2010 | -$28.55M(-76.1%) | -$5.82M(+36.9%) | -$28.55M(-118.0%) |
| Sep 2010 | - | -$9.23M(-10.9%) | -$13.10M(-45.6%) |
| Jun 2010 | - | -$8.32M(-60.4%) | -$9.00M(+27.1%) |
| Mar 2010 | - | -$5.19M(-153.8%) | -$12.35M(+23.9%) |
| Dec 2009 | -$16.22M | $9.64M(+288.0%) | -$16.22M(+46.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$5.13M(+56.1%) | -$30.39M(+2.5%) |
| Jun 2009 | - | -$11.67M(-28.8%) | -$31.19M(-22.6%) |
| Mar 2009 | - | -$9.06M(-99.7%) | -$25.43M(-21.8%) |
| Dec 2008 | -$20.87M(+16.5%) | -$4.54M(+23.3%) | -$20.87M(+35.5%) |
| Sep 2008 | - | -$5.92M(-0.1%) | -$32.34M(-3.8%) |
| Jun 2008 | - | -$5.92M(-31.4%) | -$31.16M(-19.4%) |
| Mar 2008 | - | -$4.50M(+71.9%) | -$26.10M(-4.4%) |
| Dec 2007 | -$25.00M(-64.3%) | -$16.00M(-237.6%) | -$25.00M(-4.7%) |
| Sep 2007 | - | -$4.74M(-454.5%) | -$23.87M(+25.7%) |
| Jun 2007 | - | -$855.00K(+74.8%) | -$32.14M(+28.5%) |
| Mar 2007 | - | -$3.40M(+77.2%) | -$44.96M(-195.5%) |
| Dec 2006 | -$15.21M(+34.8%) | -$14.88M(-14.3%) | -$15.21M(-149.8%) |
| Sep 2006 | - | -$13.01M(+4.8%) | -$6.09M(-878.7%) |
| Jun 2006 | - | -$13.67M(-151.9%) | $781.80K(-90.8%) |
| Mar 2006 | - | $26.35M(+558.0%) | $8.54M(+136.6%) |
| Dec 2005 | -$23.35M(-28.6%) | -$5.75M(+6.3%) | -$23.35M(-1.5%) |
| Sep 2005 | - | -$6.14M(-3.8%) | -$23.01M(-11.0%) |
| Jun 2005 | - | -$5.92M(-6.8%) | -$20.73M(-6.5%) |
| Mar 2005 | - | -$5.54M(-2.2%) | -$19.47M(-7.3%) |
| Dec 2004 | -$18.15M(-62.1%) | -$5.42M(-40.2%) | -$18.15M(-17.6%) |
| Sep 2004 | - | -$3.86M(+16.9%) | -$15.44M(-5.7%) |
| Jun 2004 | - | -$4.65M(-10.3%) | -$14.61M(-14.5%) |
| Mar 2004 | - | -$4.22M(-55.9%) | -$12.76M(-14.0%) |
| Dec 2003 | -$11.20M(+31.6%) | -$2.71M(+10.6%) | -$11.20M(-4.2%) |
| Sep 2003 | - | -$3.03M(-8.0%) | -$10.74M(+3.0%) |
| Jun 2003 | - | -$2.81M(-5.6%) | -$11.08M(+14.7%) |
| Mar 2003 | - | -$2.66M(-18.1%) | -$12.98M(+20.7%) |
| Dec 2002 | -$16.36M(-61.1%) | -$2.25M(+33.1%) | -$16.36M(+5.9%) |
| Sep 2002 | - | -$3.36M(+28.6%) | -$17.39M(-7.3%) |
| Jun 2002 | - | -$4.71M(+22.0%) | -$16.21M(-16.1%) |
| Mar 2002 | - | -$6.04M(-84.1%) | -$13.97M(-37.5%) |
| Dec 2001 | -$10.16M(-219.7%) | -$3.28M(-50.3%) | -$10.16M(-17.3%) |
| Sep 2001 | - | -$2.18M(+11.4%) | -$8.66M(-0.5%) |
| Jun 2001 | - | -$2.46M(-10.4%) | -$8.61M(-11.4%) |
| Mar 2001 | - | -$2.23M(-25.4%) | -$7.74M(-143.4%) |
| Dec 2000 | -$3.18M(+35.2%) | -$1.78M(+16.8%) | -$3.18M(-87.1%) |
| Sep 2000 | - | -$2.14M(-35.0%) | -$1.70M(-2.4%) |
| Jun 2000 | - | -$1.58M(-168.1%) | -$1.66M(-6240.7%) |
| Mar 2000 | - | $2.33M(+875.7%) | $27.00K(+100.6%) |
| Dec 1999 | -$4.90M(-16.7%) | -$300.00K(+85.7%) | -$4.90M(-880.0%) |
| Sep 1999 | - | -$2.10M(-2200.0%) | -$500.00K(+58.3%) |
| Jun 1999 | - | $100.00K(+103.8%) | -$1.20M(+71.4%) |
| Mar 1999 | - | -$2.60M(-163.4%) | -$4.20M(0.0%) |
| Dec 1998 | -$4.20M(+59.2%) | $4.10M(+246.4%) | -$4.20M(+62.8%) |
| Sep 1998 | - | -$2.80M(+3.4%) | -$11.30M(-2.7%) |
| Jun 1998 | - | -$2.90M(-11.5%) | -$11.00M(-13.4%) |
| Mar 1998 | - | -$2.60M(+13.3%) | -$9.70M(+5.8%) |
| Dec 1997 | -$10.30M(-51.5%) | -$3.00M(-20.0%) | -$10.30M(-15.7%) |
| Sep 1997 | - | -$2.50M(-56.3%) | -$8.90M(-2.3%) |
| Jun 1997 | - | -$1.60M(+50.0%) | -$8.70M(-8.8%) |
| Mar 1997 | - | -$3.20M(-100.0%) | -$8.00M(-17.6%) |
| Dec 1996 | -$6.80M(+11.7%) | -$1.60M(+30.4%) | -$6.80M(0.0%) |
| Sep 1996 | - | -$2.30M(-155.6%) | -$6.80M(-7.9%) |
| Jun 1996 | - | -$900.00K(+55.0%) | -$6.30M(+4.5%) |
| Mar 1996 | - | -$2.00M(-25.0%) | -$6.60M(+14.3%) |
| Dec 1995 | -$7.70M(-18.5%) | -$1.60M(+11.1%) | -$7.70M(-1.3%) |
| Sep 1995 | - | -$1.80M(-50.0%) | -$7.60M(+1.3%) |
| Jun 1995 | - | -$1.20M(+61.3%) | -$7.70M(+2.5%) |
| Mar 1995 | - | -$3.10M(-106.7%) | -$7.90M(-21.5%) |
| Dec 1994 | -$6.50M | -$1.50M(+21.1%) | -$6.50M(-30.0%) |
| Sep 1994 | - | -$1.90M(-35.7%) | -$5.00M(-61.3%) |
| Jun 1994 | - | -$1.40M(+17.6%) | -$3.10M(-82.4%) |
| Mar 1994 | - | -$1.70M | -$1.70M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of BCRX is -$52.02M
What is the all-time high annual cash from operations for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual cash from operations is -$3.18M
What is BioCryst Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, BCRX annual cash from operations has changed by +$43.12M (+45.32%)
What is BioCryst Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of BCRX is $41.30M
What is the all-time high quarterly cash from operations for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly cash from operations is $41.30M
What is BioCryst Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, BCRX quarterly cash from operations has changed by +$42.67M (+3119.15%)
What is BioCryst Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of BCRX is $16.82M
What is the all-time high TTM cash from operations for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM cash from operations is $16.82M
What is BioCryst Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, BCRX TTM cash from operations has changed by +$100.68M (+120.05%)